Literature DB >> 11090101

Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes.

S L Cruz1, R L Balster, J J Woodward.   

Abstract

1. We have previously shown that toluene dose-dependently inhibits recombinant N-methyl-D-aspartate (NMDA) receptors at micromolar concentrations. This inhibition was rapid, almost complete and reversible. The NR1/2B combination was the most sensitive receptor subtype tested with an IC(50) value for toluene of 0.17 mM. 2. We now report on the effects of other commonly abused solvents (benzene, m-xylene, ethylbenzene, propylbenzene, 1,1,1-trichlorethane (TCE) and those of a convulsive solvent, 2,2,2-trifluoroethyl ether (flurothyl), on NMDA-induced currents measured in XENOPUS oocytes expressing NR1/2A or NR1/2B receptor subtypes. 3. All of the alkylbenzenes and TCE produced a reversible inhibition of NMDA-induced currents that was dose- and subunit-dependent. The NR1/2B receptor subtype was several times more sensitive to these compounds than the NR1/2A subtype. 4. The convulsant solvent flurothyl had no effect on NMDA responses in oocytes but potently inhibited ion flux through recombinant GABA receptors expressed in oocytes. 5. Overall, these results suggest that abused solvents display pharmacological selectivity and that NR1/2B NMDA receptors may be an important target for the actions of these compounds on the brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090101      PMCID: PMC1572451          DOI: 10.1038/sj.bjp.0703666

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

Review 1.  Worksite behavioral research. Results, sensitive methods, test batteries and the transition from laboratory data to human health.

Authors:  W K Anger
Journal:  Neurotoxicology       Date:  1990       Impact factor: 4.294

Review 2.  CNS depressant effects of volatile organic solvents.

Authors:  E B Evans; R L Balster
Journal:  Neurosci Biobehav Rev       Date:  1991       Impact factor: 8.989

Review 3.  Noncompetitive excitatory amino acid receptor antagonists.

Authors:  D Lodge; K M Johnson
Journal:  Trends Pharmacol Sci       Date:  1990-02       Impact factor: 14.819

4.  Ethanol inhibits NMDA-activated ion current in hippocampal neurons.

Authors:  D M Lovinger; G White; F F Weight
Journal:  Science       Date:  1989-03-31       Impact factor: 47.728

5.  Chronic non-neurological toxicity from volatile substance abuse.

Authors:  R Marjot; A A McLeod
Journal:  Hum Toxicol       Date:  1989-07

6.  Acute toluene poisoning during painting.

Authors:  S Takeichi; T Yamada; I Shikata
Journal:  Forensic Sci Int       Date:  1986-10       Impact factor: 2.395

7.  An overview of environmental and toxicological aspects of aromatic hydrocarbons. III. Xylene.

Authors:  L Fishbein
Journal:  Sci Total Environ       Date:  1985-05       Impact factor: 7.963

8.  Influence of organic solvent mixtures on biological membranes.

Authors:  C Gustafson; C Tagesson
Journal:  Br J Ind Med       Date:  1985-09

9.  Fatal poisoning by 1,1,1-trichloroethane after prolonged survival.

Authors:  G A Gresham; C S Treip
Journal:  Forensic Sci Int       Date:  1983 Nov-Dec       Impact factor: 2.395

10.  Partition coefficients of some aromatic hydrocarbons and ketones in water, blood and oil.

Authors:  A Sato; T Nakajima
Journal:  Br J Ind Med       Date:  1979-08
View more
  23 in total

Review 1.  Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts.

Authors:  Christoph van Thriel; Remco H S Westerink; Christian Beste; Ambuja S Bale; Pamela J Lein; Marcel Leist
Journal:  Neurotoxicology       Date:  2011-10-12       Impact factor: 4.294

2.  Differential effects of TM4 tryptophan mutations on inhibition of N-methyl-d-aspartate receptors by ethanol and toluene.

Authors:  C Thetford Smothers; John J Woodward
Journal:  Alcohol       Date:  2016-10-03       Impact factor: 2.405

3.  Binge toluene exposure alters glutamate, glutamine and GABA in the adolescent rat brain as measured by proton magnetic resonance spectroscopy.

Authors:  Shane A Perrine; Shonagh K O'Leary-Moore; Matthew P Galloway; John H Hannigan; Scott E Bowen
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

4.  GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Drug Alcohol Depend       Date:  2011-09-15       Impact factor: 4.492

Review 5.  Volatile solvents as drugs of abuse: focus on the cortico-mesolimbic circuitry.

Authors:  Jacob T Beckley; John J Woodward
Journal:  Neuropsychopharmacology       Date:  2013-08-19       Impact factor: 7.853

6.  Inhibition of neuronal nicotinic acetylcholine receptors by the abused solvent, toluene.

Authors:  Ambuja S Bale; Corigan T Smothers; John J Woodward
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  Benzodiazepine-like discriminative stimulus effects of toluene vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Eur J Pharmacol       Date:  2013-11-15       Impact factor: 4.432

8.  Neurochemical changes after acute binge toluene inhalation in adolescent and adult rats: a high-resolution magnetic resonance spectroscopy study.

Authors:  Shonagh K O'Leary-Moore; Matthew P Galloway; Andrew P McMechan; Susan Irtenkauf; John H Hannigan; Scott E Bowen
Journal:  Neurotoxicol Teratol       Date:  2009-07-21       Impact factor: 3.763

9.  Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene.

Authors:  Jacob T Beckley; Patrick K Randall; Rachel J Smith; Benjamin A Hughes; Peter W Kalivas; John J Woodward
Journal:  Addict Biol       Date:  2015-03-06       Impact factor: 4.280

10.  Abused inhalants enhance GABA-mediated synaptic inhibition.

Authors:  M Bruce MacIver
Journal:  Neuropsychopharmacology       Date:  2009-06-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.